The Current Landscape of Anticoagulation Stewardship Implementation in the United States and Around the World: An International Survey

ABSTRACT Background Little is known about the familiarity and implementation of anticoagulation (AC) stewardship on a global scale. Therefore, we aimed to identify current AC stewardship patterns globally. Methods An international survey was electronically distributed to individuals involved with AC as a practitioner, researcher, or administrator between June and September 2024. Results A total of 985 responses (790 United States [U.S.]/195 non‐U.S.) representing 65 countries/regions and 50 U.S. states. Most respondents were physicians (51.9%) or pharmacists (24.2%). 93.7% felt AC safety was a serious concern in their country; 90.5% were at least moderately familiar with the term AC stewardship. Only 52.1% have an AC stewardship program for hospitalized, ambulatory, or both patient populations. Most (73.4%) felt their organization does a good job implementing clinical guidelines/protocols for AC stewardship, most commonly for direct oral anticoagulants (DOACs) (37.0%), low molecular weight heparin (LMWH) (36.5%), intravenous unfractionated heparin (IV UFH) (35.9%), and warfarin (34.3%). Most commonly tracked quality measures were AC reversal (38.5%), rates of major bleeding (33.1%), number of international normalized ratios (INRs) > 5 (32.8%), and warfarin time in therapeutic range (31.4%). 82.2% felt their organization's leadership supports AC stewardship with dedicated resources, including dedicated time to complete AC stewardship (51.1%), dedicated AC stewardship positions (56.5%), and financial support for training (36.3%). Conclusion Respondents were familiar with the term AC stewardship, and many organizations have a supportive leadership structure in place for AC stewardship activities, but only half of the respondents felt they have an AC stewardship program in place. Many organizations have not implemented systematic care that includes the use of common clinical guidelines or protocols, and they are not tracking common quality measures. Opportunities exist for further development of AC stewardship services worldwide.

Authors

Institutions

Publication Details

Journal
JACCP JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY
Published
2026-02-22
DOI
https://doi.org/10.1002/jac5.70189
Primary Topic
Atrial Fibrillation Management and Outcomes
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

The Current Landscape of Anticoagulation Stewardship Implementation in the United States and Around the World: An International Survey

Grace A. McGee, Nancy L Shapiro, Allison E. Burnett
JACCP JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY
Atrial Fibrillation Management and Outcomes
article

The Current Landscape of Anticoagulation Stewardship Implementation in the United States and Around the World: An International Survey

Grace A. McGee, Nancy L Shapiro, Allison E. Burnett
article en

Abstract

ABSTRACT Background Little is known about the familiarity and implementation of anticoagulation (AC) stewardship on a global scale. Therefore, we aimed to identify current AC stewardship patterns globally. Methods An international survey was electronically distributed to individuals involved with AC as a practitioner, researcher, or administrator between June and September 2024. Results A total of 985 responses (790 United States [U.S.]/195 non‐U.S.) representing 65 countries/regions and 50 U.S. states. Most respondents were physicians (51.9%) or pharmacists (24.2%). 93.7% felt AC safety was a serious concern in their country; 90.5% were at least moderately familiar with the term AC stewardship. Only 52.1% have an AC stewardship program for hospitalized, ambulatory, or both patient populations. Most (73.4%) felt their organization does a good job implementing clinical guidelines/protocols for AC stewardship, most commonly for direct oral anticoagulants (DOACs) (37.0%), low molecular weight heparin (LMWH) (36.5%), intravenous unfractionated heparin (IV UFH) (35.9%), and warfarin (34.3%). Most commonly tracked quality measures were AC reversal (38.5%), rates of major bleeding (33.1%), number of international normalized ratios (INRs) > 5 (32.8%), and warfarin time in therapeutic range (31.4%). 82.2% felt their organization's leadership supports AC stewardship with dedicated resources, including dedicated time to complete AC stewardship (51.1%), dedicated AC stewardship positions (56.5%), and financial support for training (36.3%). Conclusion Respondents were familiar with the term AC stewardship, and many organizations have a supportive leadership structure in place for AC stewardship activities, but only half of the respondents felt they have an AC stewardship program in place. Many organizations have not implemented systematic care that includes the use of common clinical guidelines or protocols, and they are not tracking common quality measures. Opportunities exist for further development of AC stewardship services worldwide.

JACCP JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACYVol. 9(3)
University of New Mexico Hospital (US), University of Illinois Chicago (US)
Partnerships for the goals
Openalex Percentile: Top 50%
Atrial Fibrillation Management and Outcomes
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.